| |
| |
|
| Insider
Information: |
Henneman John B III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
263,813 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,807,852 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
263,813 |
|
|
| Total
Value |
$3,807,852 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -27.9%
|
-30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
|
R1 Rcm Inc |
RCM |
Director |
2024-05-23 |
87,765 |
2022-06-21 |
0 |
Premium* |
|
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
168 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACHI |
R1 RCM Inc |
Director |
– • – |
2022-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,151 |
54,751 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,943 |
82,654 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,954 |
23,436 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
60,790 |
60,790 |
0 |
- |
|
| ACHI |
R1 RCM Inc |
Director |
– • – |
2022-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,751) |
0 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
15,605 |
0 |
- |
|
| OFIX |
Orthofix International N.... |
Director |
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,052 |
48,460 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2023-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(82,654) |
0 |
0 |
- |
|
| OFIX |
Orthofix International N.... |
Director |
– • – |
2023-01-05 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,354 |
48,762 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,324 |
72,114 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
29,936 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2023-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
1,279 |
0 |
- |
|
| RCM |
R1 Rcm Inc |
Director |
– • – |
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,651 |
87,765 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2018-01-02 |
4 |
D |
$8.47 |
$1,389 |
D/D |
(164) |
58,859 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2017-01-03 |
4 |
D |
$10.28 |
$1,686 |
D/D |
(164) |
59,935 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. V.P., CAO, Secretary |
• – – |
2005-03-14 |
4 |
OE |
$3.50 |
$2,188 |
D/D |
625 |
31,925 |
|
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Administrative Officer |
• – – |
2018-10-01 |
4 |
D |
$2.28 |
$5,664 |
D/D |
(2,484) |
55,052 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2016-01-05 |
4 |
S |
$35.74 |
$6,255 |
D/D |
(175) |
62,316 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2018-01-04 |
4 |
D |
$10.06 |
$13,309 |
D/D |
(1,323) |
57,536 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP and CAO |
• – – |
2007-06-01 |
4 |
OE |
$26.70 |
$13,350 |
D/D |
500 |
23,072 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2017-01-04 |
4 |
D |
$11.04 |
$14,606 |
D/D |
(1,323) |
58,612 |
0 |
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, & Secretary |
• – – |
2005-02-01 |
4 |
OE |
$3.50 |
$16,118 |
D/D |
4,605 |
35,905 |
|
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
• – – |
2003-07-14 |
4 |
OE |
$3.38 |
$16,175 |
D/D |
4,000 |
0 |
|
- |
|
| IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, & Secretary |
• – – |
2003-08-11 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
| IART |
Integra Lifesciences Hold... |
Exec VP, CAO, Secretary |
• – – |
2003-09-08 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
168 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
